Search Results - "ZURAEK, Marlene B"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors

    Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors by Wang, Yu-Cheng, Gallego-Arteche, Emerick, Iezza, Gioia, Yuan, Xiaochen, Matli, Mary R, Choo, Su-Pin, Zuraek, Marlene B, Gogia, Ravi, Lynn, Francis C, German, Michael S, Bergsland, Emily K, Donner, David B, Warren, Robert S, Nakakura, Eric K

    Published in Endocrine-related cancer (01-03-2009)
    “…The homeodomain transcription factor NKX2.2 is necessary for neuroendocrine (NE) differentiation in the central nervous system and pancreas. NE tumors derived…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine

    The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine by Wang, Yu-cheng, Zuraek, Marlene B, Kosaka, Yasuhiro, Ota, Yasuharu, German, Michael S, Deneris, Evan S, Bergsland, Emily K, Donner, David B, Warren, Robert S, Nakakura, Eric K

    Published in Endocrine-related cancer (01-03-2010)
    “…Neuroendocrine (NE) or carcinoid tumors of the small intestine (SI) frequently metastasize and produce the hormone serotonin, causing significant morbidity and…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Lack of NKX2.2 Expression in Bronchopulmonary Typical Carcinoid Tumors: Implications for Patients with Neuroendocrine Tumor Metastases and Unknown Primary Site

    Lack of NKX2.2 Expression in Bronchopulmonary Typical Carcinoid Tumors: Implications for Patients with Neuroendocrine Tumor Metastases and Unknown Primary Site by Wang, Yu-cheng, Ph.D, Iezza, Gioia, M.D, Zuraek, Marlene B., M.D, Jablons, David M., M.D, Theodore, Pierre R., M.D, Bergsland, Emily K., M.D, Donner, David B., Ph.D, Warren, Robert S., M.D, Nakakura, Eric K., M.D., Ph.D

    Published in The Journal of surgical research (01-09-2010)
    “…Background Patients with neuroendocrine tumors (NETs) may have metastatic disease and unknown primary site. NETs commonly arise from the bronchopulmonary (BP)…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Fractional Genomic Alteration Detected by Array-Based Comparative Genomic Hybridization Independently Predicts Survival after Hepatic Resection for Metastatic Colorectal Cancer

    Fractional Genomic Alteration Detected by Array-Based Comparative Genomic Hybridization Independently Predicts Survival after Hepatic Resection for Metastatic Colorectal Cancer by MEHTA, Kshama R, NAKAO, Kentaro, TERDIMAN, Jonathan P, WALDMAN, Frederic M, ZURAEK, Marlene B, RUAN, Daniel T, BERGSLAND, Emily K, VENOOK, Alan P, MOORE, Dan H, TOKUYASU, Taku A, JAIN, Ajay N, WARREN, Robert S

    Published in Clinical cancer research (01-03-2005)
    “…Purpose: Although liver resection is the primary curative therapy for patients with colorectal hepatic metastases, most patients have a recurrence…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Association of TP53 Mutational Status and Gender with Survival after Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803

    Association of TP53 Mutational Status and Gender with Survival after Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803 by WARREN, Robert S, ATREYA, Chloe E, SALTZ, Leonard B, BERTAGNOLLI, Monica M, NIEDZWIECKI, Donna, WEINBERG, Vivian K, DONNER, David B, MAYER, Robert J, GOLDBERG, Richard M, COMPTON, Carolyn C, ZURAEK, Marlene B, YE, Cynthia

    Published in Clinical cancer research (15-10-2013)
    “…The TP53 tumor suppressor is frequently mutated in colon cancer, but the influence of such mutations on survival remains controversial. We investigated whether…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Aggressive surgery for metastatic liver neuroendocrine tumors

    Aggressive surgery for metastatic liver neuroendocrine tumors by Norton, Jeffrey A, Warren, Robert S, Kelly, Mary G, Zuraek, Marlene B, Jensen, Robert T

    Published in Surgery (01-12-2003)
    “…Neuroendocrine tumors of the gastrointestinal tract (carcinoids, pancreatic endocrine tumors) have low malignant potential but can decrease survival rates if…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  7. 7
    Identification of unknown primary tumors in patients with neuroendocrine liver metastases

    Identification of unknown primary tumors in patients with neuroendocrine liver metastases by Wang, Sam C, Parekh, Justin R, Zuraek, Marlene B, Venook, Alan P, Bergsland, Emily K, Warren, Robert S, Nakakura, Eric K

    Published in Archives of surgery (Chicago. 1960) (01-03-2010)
    “…For patients with neuroendocrine tumor (NET) liver metastases, resection of the primary tumor may prevent local complications (obstruction, ischemia, and…”
    Get more information
    Journal Article
    Save to List
    Saved in:
  8. 8
    Prognostic importance of superior diaphragmatic adenopathy at computed tomography in patients with resectable hepatic metastases from colorectal carcinoma

    Prognostic importance of superior diaphragmatic adenopathy at computed tomography in patients with resectable hepatic metastases from colorectal carcinoma by Aslam, Rizwan, Coakley, Fergus V, Williams, Gethin, Yeh, Benjamin M, Joe, Bonnie N, Zuraek, Marlene B, Warren, Robert S

    Published in Journal of computer assisted tomography (01-03-2008)
    “…To determine the prognostic importance of superior diaphragmatic adenopathy at CT in patients with resectable hepatic metastases from colorectal carcinoma. We…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  9. 9
    Identification of Unknown Primary Tumors in Patients With Neuroendocrine Liver Metastases

    Identification of Unknown Primary Tumors in Patients With Neuroendocrine Liver Metastases by Nakakura, Eric K., Wang, Sam C., Parekh, Justin R., Zuraek, Marlene B., P., Alan, Bergsland, Emily K., Warren, Robert S.

    Published in Pancreas (01-03-2010)
    Get full text
    Journal Article
    Save to List
    Saved in:
  10. 10
    Lack of NKX2.2 Expression in BronchopulmonaryTypical Carcinoid Tumors: Implications for Patients with Neuroendocrine Tumor Metastases and Unknown Primary Site

    Lack of NKX2.2 Expression in BronchopulmonaryTypical Carcinoid Tumors: Implications for Patients with Neuroendocrine Tumor Metastases and Unknown Primary Site by WANG, Yu-Cheng, IEZZA, Gioia, ZURAEK, Marlene B, JABLONS, David M, THEODORE, Pierre R, BERGSLAND, Emily K, DONNER, David B, WARREN, Robert S, NAKAKURA, Eric K

    Get full text
    Conference Proceeding
    Save to List
    Saved in:
  11. 11
    Aggressive surgery for metastatic liver neuroendocrine tumors. Discussion

    Aggressive surgery for metastatic liver neuroendocrine tumors. Discussion by NORTON, Jeffrey A, WARREN, Robert S, SKOGSEID, Britt, KELLY, Mary G, ZURAEK, Marlene B, JENSEN, Robert T, FAHEY, Thomas J, THOMPSON, Norman W, SNYDER, Samuel K, PASIEKA, Janice L, MITCHELL, Bradford

    Published in Surgery (2003)
    Get full text
    Conference Proceeding
    Save to List
    Saved in:

Search Tools: